Vitamin K2 Market Players:
- Kappa Bioscience Group
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gnosis by Lesaffre
- Koninklijke DSM N.V
- Pfizer Inc.
- Viridis BioPharma Pvt. Ltd.
- DuPont de Nemours, Inc.
- Seebio Biotech (Shanghai) Co., Ltd.
- GeneFerm Biotechnology Co., Ltd.
- Kyowa Hakka Bio Co., Ltd.
- International Flavors & Fragrances Inc.
The competitive landscape of the Vitamin K2 market is rapidly evolving as established key players and new entrants are investing in launching quality supplements. Key players in the market are focused on developing new technologies and products catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of vitamin K2 is estimated at USD 272.55 Million.
The global vitamin K2 market size was more than USD 243.41 Million in 2025 and is anticipated to grow at a CAGR of over 13.3%, reaching USD 848.47 Million revenue by 2035.
North America vitamin K2 market is predicted to capture 36.1% share by 2035, driven by the increasing health focus and osteoporosis awareness in the region.
Key players in the market include Kappa Bioscience Group, Gnosis by Lesaffre, Koninklijke DSM N.V, Pfizer Inc., Viridis BioPharma Pvt. Ltd., DuPont de Nemours, Inc., Seebio Biotech (Shanghai) Co., Ltd., GeneFerm Biotechnology Co., Ltd., Kyowa Hakka Bio Co., Ltd., International Flavors & Fragrances Inc.
